Publications by authors named "R Deva"

Article Synopsis
  • Testosterone is a key male hormone involved in sex differentiation and development, primarily produced in the testes and related glands from cholesterol.
  • The review highlights various studies exploring testosterone's potential benefits beyond its current use for treating specific hormonal disorders, specifically looking at its effects on conditions like anxiety and diabetes.
  • The authors aim to promote an understanding of testosterone's therapeutic uses while advocating for optimal hormonal balance to improve health outcomes for conditions such as obesity and depression.
View Article and Find Full Text PDF

Background: Diabetic foot infections (DFIs) represent a significant complication of diabetes mellitus, contributing to increased morbidity and mortality. Understanding antibiotic prescribing patterns and microbial susceptibility is crucial for effective management.

Objective: This study aimed to assess antibiotic prescribing trends and microbial susceptibility patterns in DFIs in a tertiary care center in Puducherry.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between genetic variations (specifically, ITPA C94A polymorphism) and adverse effects caused by the immunosuppressant azathioprine (AZA) in patients with immune disorders.
  • A total of 120 patients undergoing AZA therapy were analyzed, involving blood collection and DNA testing to evaluate their genetic makeup.
  • Results indicate no significant correlation between the ITPA polymorphism and the adverse effects of AZA among South Indian patients, suggesting genetic factors may not heavily influence AZA-related side effects in this population.
View Article and Find Full Text PDF

A 69-year-old male presented with early stage non-small cell lung cancer in 2016. The tumor was resected; however, the patient experienced recurrence 2 years later and subsequently received paclitaxel/carboplatin concurrently with radiotherapy. Within weeks of completing this treatment, he developed a symptomatic pancoast tumor secondary to disease progression and commenced second line nivolumab.

View Article and Find Full Text PDF

Background/aims: Individuals who reach end-stage kidney disease (CKD5) have a high risk of vascular events that persists even after renal transplantation. This study compared the prevalence and severity of microvascular disease in transplant recipients and patients with CKD5.

Methods: Individuals with a renal transplant or CKD5 were recruited consecutively from renal clinics, and underwent bilateral retinal photography (Canon CR5-45, Canon).

View Article and Find Full Text PDF